Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
ADAM17 and its inhibitor TIMP3 are involved in nephropathy, but their role in diabetic kidney disease (DKD) is unclear. Diabetic Timp3 −/− mice showed increased albuminuria, increased membrane thickness and mesangial expansion. Microarray profiling uncovered a significant reduction of Foxo1 expression in diabetic Timp3 −/− mice compared to WT, along with FoxO1 target genes involved in autophagy, while STAT1, a repressor of FoxO1 transcription, was increased. Re‐expression of Timp3 in Timp3 −/− mesangial cells rescued the expression of Foxo1 and its targets, and decreased STAT1 expression to control levels; abolishing STAT1 expression led to a rescue of FoxO1, evoking a role of STAT1 in linking Timp3 deficiency to FoxO1. Studies on kidney biopsies from patients with diabetic nephropathy confirmed a significant reduction in TIMP3, FoxO1 and FoxO1 target genes involved in autophagy compared to controls, while STAT1 expression was strongly increased. Our study suggests that loss of TIMP3 is a hallmark of DKD in human and mouse models and designates TIMP3 as a new possible therapeutic target for diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“restoration of TIMP3 expression in GMCs from Timp3−/− mice by transfection with a Timp3 adenovirus reversed the impairment in autophagy.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cultured GMCs exposed to high-glucose, Timp3 deletion suppressed autophagy by reducing the expression of FOXO1a and its target ATG genes”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
The cited source says what the claim attributes to it.
In the citing paper
“Timp3 deletion exacerbated diabetic kidney injury in mice160.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
In the citing paper
“The metalloproteinase inhibitor 3 gene (Timp3) was downregulated in the kidney of STZ-induced diabetic mice and in patients with diabetes, as well as in GMCs treated with high glucose”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“…be induced by intracellular stresses that are involved in the pathogenesis of diabetic nephropathy including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et…”
[9] TM4 Microarray Software Suite
Saeed, A. I., Bhagabati, N. K., Braisted, J. C., Liang, W., Sharov, V., Howe, E. A., Li, J., Thiagarajan, M., White, J. A., & Quackenbush, J. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)11009-5 · Cited by 1,983 · cited 1×
“Heatmaps and hierarchical clusters were created using MeV 4.4 (MultiExperiment Viewer, TM4 suite; Saeed et al, 2006).”
InfluentialZhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.004 · Cited by 1,489 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
Autophagy is required to maintain muscle mass.
Masiero, E., Agatea, L., Mammucari, C., Blaauw, B., Loro, E., Komatsu, M., Metzger, D., Reggiani, C., Schiaffino, S., & Sandri, M. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.10.008 · Cited by 1,282 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
ADAMs: key components in EGFR signalling and development
Blobel, C. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1548 · Cited by 1,090 · cited 1×
“ADAM17, also known as TNF-a converting enzyme (TACE), mediates the shedding of TNF-a and its receptors (TNFRI and II), adhesion molecules ( L -selectin, VCAM), and several EGFR ligands, such as amphiregulin, TGF-a and heparin-binding EGF-Research like growth factor (HB-EGF; Blobel, 2000, 2005).”
The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy
Mogensen, C. E., Christensen, C. K., & Vittinghus, E. (1983) · Diabetes · doi:10.2337/diab.32.2.s64 · Cited by 967 · cited 1×
“Poor glycaemic control and elevated systolic blood pressure exacerbate proteinuria and renal injury that may culminate in end-stage renal disease (Lane et al, 1990; Mogensen et al, 1983).”
Redox Regulation of Forkhead Proteins Through a p66shc -Dependent Signaling Pathway
Nemoto, S., & Finkel, T. (2002) · Science · doi:10.1126/science.1069004 · Cited by 818 · cited 2×
“…2D FoxO1 regulation in diabetic Timp3 (cid:1) / (cid:1) kidneys Giving the importance of FoxO1 in regulating cell survival and oxidative stress (Nemoto & Finkel, 2002), and renal neoplastic cell proliferation (Gan et al, 2010), we next focused on FoxO1 regulation in STZ-Timp3 (cid:1) / (cid:1)…”
Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S. J., Lindenmeyer, M. T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39492 · Cited by 721 · cited 1×
“…including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et al, 2011; Hartleben et al, 2010; He et al, 2010; Inoki et al, 2011; Kume et al, 2010; Nath, 2010).”
Hariharan, N., Maejima, Y., Nakae, J., Paik, J., DePinho, R. A., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.110.227371 · Cited by 692 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A., & Anand-Apte, B. (2003) · Nature Medicine · doi:10.1038/nm846 · Cited by 658 · cited 2×
“Through gene expression profiling of Timp3 (cid:1) / (cid:1) diabetic kidneys, our study confirms that many critical mediators of inflammation and proliferation are found up-regulated, although we did not observe a perturbation of the VEGFR pathway that has been reported to bind TIMP3 (Qi et al, 2003).”
Cited by
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
“MicroRNAs (miRs) play important roles in the initiation and progression of many pathological processes, such as diabetic nephropathy [69] and retinopathy [112].”
BackgroundAutophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
The return of the nucleus: transcriptional and epigenetic control of autophagy
Füllgrabe, J., Klionsky, D. J., & Joseph, B. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3716 · Cited by 466
Autophagy in diabetic nephropathy
Ding, Y., & Choi, M. E. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0437 · Cited by 306
“Furthermore, knockdown of TIMP3 in mesangial cells, either by shRNA or genetic deletion in primary mesangial cells obtained from Timp3-null mice, recapitulated FOXO1 downregulation in vivo and inhibition of autophagy (Fiorentino et al. 2013).”
BackgroundInfluentialRegulation of autophagy by stress-responsive transcription factors
Pietrocola, F., Izzo, V., Niso-Santano, M., Vacchelli, E., Galluzzi, L., Maiuri, M. C., & Kroemer, G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.05.008 · Cited by 268
Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
Yang, D., Livingston, M. J., Liu, Z., Dong, G., Zhang, M., Chen, J.-K., & Dong, Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2639-1 · Cited by 252
“Re-expression of TIMP3 in these mesangial cells rescued the expression of FoxO1 and its targets, reduced STAT1 expression, and as a result, reversed autophagy inhibition [184].”
BackgroundThe FoxO–Autophagy Axis in Health and Disease
Cheng, Z. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.07.009 · Cited by 255
Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy
Wang, X., Liu, J., Zhen, J., Zhang, C., Wan, Q., Liu, G., Wei, X., Zhang, Y., Wang, Z., Han, H., et al. (2014) · Kidney International · doi:10.1038/ki.2014.111 · Cited by 244
Transcriptional regulation of mammalian autophagy at a glance
Füllgrabe, J., Ghislat, G., Cho, D.-H., & Rubinsztein, D. C. (2016) · Journal of Cell Science · doi:10.1242/jcs.188920 · Cited by 198
“The transcription factor X-box-binding protein 1 (XBP1) is another crucial regulator of FOXO1 activation and degradation.”
BackgroundInfluentialRethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
Marshall, C. B. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00313.2016 · Cited by 168
“In diabetic mouse models, TIMP3 knockout results in significantly increased mean glomerular area, GBM thickening, and albuminuria (16, 52).”
BackgroundMicroRNA-21 in Glomerular Injury
Lai, J. Y., Luo, J., O'Connor, C. L., Jing, X., Nair, V., Ju, W., Randolph, A. E., Ben‐Dov, I. Z., Matar-Ujvary, R., Briskin, D., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121274 · Cited by 148
Zang, J., Maxwell, A. P., Simpson, D. A. C., & McKay, G. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-47504-x · Cited by 139
Huang, F., Wang, Q., Guo, F., Zhao, Y., Ji, L., An, T., Song, Y., Liu, Y., He, Y., & Qin, G. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.002 · Cited by 124
Tregs restrain dendritic cell autophagy to ameliorate autoimmunity
Alissafi, T., Banos, A., Boon, L., Sparwasser, T. D., Ghigo, A., Wing, K., Vassilopoulos, D., Boumpas, D. T., Chavakis, T., Cadwell, K., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92079 · Cited by 129
“Mechanistically, CTLA4 binding promoted activation of the PI3K/Akt/mTOR axis and FoxO1 nuclear exclusion in DCs, leading to decreased transcription of the autophagy component microtubule-associated protein 1 light chain 3β (Lc3b).”
BackgroundInfluentialInsulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice
Salem, E., Grobe, N., & Elased, K. M. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00516.2013 · Cited by 120
The role of ADAM17 in metabolic inflammation
Menghini, R., Fiorentino, L., Casagrande, V., Lauro, R., & Federici, M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.024 · Cited by 114
Self-citationNaik, P. P., Mukhopadhyay, S., Panda, P. K., Sinha, N., Das, C. K., Mishra, R., Patil, S., & Bhutia, S. K. (2017) · Cell Proliferation · doi:10.1111/cpr.12411 · Cited by 110
Haim, Y., Blüher, M., Slutsky, N., Goldstein, N., Klöting, N., Harman-Boehm, I., Kirshtein, B., Ginsberg, D., Gericke, M., Guiu Jurado, E., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1094597 · Cited by 106
“Similarly, mRNA levels of MAP1LC3B, ATG5, ATG12, ATG4B (autophagy-related 4B, cysteine peptidase) and BECN1 are elevated in response to oxidative stress by EGR1 (early growth response 1), FOXO1/2/3/4, and STAT3 in skeletal muscle cells, cardiomyocytes and hepatocytes.(58,60,62,68-71) Thus, E2F1 may interact with other…”
BackgroundThe Role of Beclin 1-Dependent Autophagy in Cancer
Vega-Rubín-de-Celis, S. (2019) · Biology · doi:10.3390/biology9010004 · Cited by 119
“Multiple transcription factors have also been linked to regulating Beclin 1 levels, including Jun [85], Forkhead box O (FOXO) family members FOXO1 and FOXO3 [86,87], Nuclear factor-kB (NFkB) [88], p63 [84], Signal Transducer and Activator of Transcription 1 (STAT1) [89], Peroxisome proliferator-activated receptor-α PP…”
BackgroundRegulating Autophagy as a Therapeutic Target for Diabetic Nephropathy
Kitada, M., Ogura, Y., Monno, I., & Koya, D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0879-y · Cited by 108
Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs
Fiorentino, L., Cavalera, M., Mavilio, M., Conserva, F., Menghini, R., Gesualdo, L., & Federici, M. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0492-8 · Cited by 88
“We have previously shown that, in a hyperglycemic environment, TIMP3 expression was strongly reduced in both mouse and human kidneys with features of DN [17].”
BackgroundMethodInfluentialSelf-citationJi, L., Wang, Q., Huang, F., An, T., Guo, F., Zhao, Y., Liu, Y., He, Y., Song, Y., & Qin, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3286928 · Cited by 90
Role of the TNF pathway in the progression of diabetic nephropathy in KK-Aymice
Omote, K., Gohda, T., Murakoshi, M., Sasaki, Y., Kazuno, S., Fujimura, T., Ishizaka, M., Sonoda, Y., & Tomino, Y. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00509.2013 · Cited by 85
miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway
Li, W., Yi, J., Zheng, X., Liu, S., Fu, W., Ren, L., Li, L., Hoon, D. S. �., Wang, J., & Du, G. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0495-y · Cited by 74
“STAT1 has been reported to exhibit a negative regulatory effect on FOXO1 transcription in pancreatic β cells [61] and bladder cancer [63].”
BackgroundCell Apoptosis and Autophagy in Renal Fibrosis
Zhao, X., Livingston, M. J., Liang, X., & Dong, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_28 · Cited by 78
A Glimpse of Matrix Metalloproteinases in Diabetic Nephropathy
Xu, X., Xiao, L., Xiao, P., Yang, S., Chen, G., Liu, F., Kanwar, Y. S., & Sun, L. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140716092052 · Cited by 81
Jiang, G., Wu, A. D., Huang, C., Gu, J., Zhang, L., Huang, H., Li, J., li, J., Zhang, D., Zeng, X., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0338 · Cited by 66
“STAT1 has been thought to exhibit a negative regulatory effect on FOXO1 transcription in pancreatic b cells (49); however, this notion has never been explored in any cancer cells.”
BackgroundFoxO1 signaling as a therapeutic target for type 2 diabetes and obesity
Benchoula, K., Arya, A., Parhar, I. S., & Wong, E. H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173758 · Cited by 67
Chen, X., Zhao, L., Xing, Y., & Lin, B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.007 · Cited by 64
RetractedTargeting VE-PTP phosphatase protects the kidney from diabetic injury
Carota, I. A., Kenig-Kozlovsky, Y., Onay, T., Scott, R. P., Thomson, B. R., Souma, T., Bartlett, C. S., Li, Y., Procissi, D., Ramirez, V., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20180009 · Cited by 69
“It has previously been reported that activation of FOXO1 in the endothelium occurs in the setting of diabetes (Battiprolu et al., 2012; Fiorentino et al., 2013) and leads to up-regulation of a number of genes promoting fibrogenesis and endothelial cell apoptosis such as Pdgfb, Ctgf, Edn1, and Angpt2 (Baelde et al.”
Conserva, F., Gesualdo, L., & Papale, M. (2015) · Journal of Diabetes Research · doi:10.1155/2016/7934504 · Cited by 66
“BECN1 Kidney Whole Down T2D qPCR Diagnostic [33]”
BackgroundInfluentialSelf-citationFabrizi, M., Marchetti, V., Mavilio, M., Marino, A., Casagrande, V., Cavalera, M., Moreno‐Navarrete, J. M., Mezza, T., Sorice, G. P., Fiorentino, L., et al. (2014) · Diabetes · doi:10.2337/db13-0939 · Cited by 61
“Gene Expression Analysis by qRT-PCR Total RNA was isolated and gene expression analysis was performed as previously described (34).”
MethodSelf-citationLópez‐López, N., Gonzalez-Curiel, I. E., Cruz, M. B. T.-S., Rivas-Santiago, B. T., Trujillo-Páez, J. V., Enciso‐Moreno, J. A., & Serrano, C. J. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1494-2 · Cited by 61
“maintaining kidney homeostasis: studies on kidney biopsies from patients with diabetic nephropathy showed a reduction in TIMP-3, compared to controls [12].”
Background4-Hydroxyisoleucine: A Potential New Treatment for Type 2 Diabetes Mellitus
Zafar, M. I., & Gao, F. (2016) · BioDrugs · doi:10.1007/s40259-016-0177-2 · Cited by 57
“The absence of TIMP3 is associated with diabetic nephropathy and accelerated atherosclerosis [31, 32].”
BackgroundStöhr, R., & Federici, M. (2013) · Biochemical Journal · doi:10.1042/bj20130121 · Cited by 58
Self-citationTargeting ADAM17 Sheddase Activity in Cancer
Rossello, A., Nuti, E., Ferrini, S., & Fabbi, M. (2016) · Current Drug Targets · doi:10.2174/1389450117666160727143618 · Cited by 51
MicroRNAs in Endothelial Senescence and Atherosclerosis
Menghini, R., Casagrande, V., & Federici, M. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9487-7 · Cited by 49
“Furthermore, SirT1 activity is critical for maintenance of TIMP3 expression, an endogenous inhibitor of metalloproteinases, involved in both atherosclerosis and metabolic disorders [25–30], in several vascular cells.”
BackgroundSelf-citationSerum level of the autophagy biomarker Beclin-1 in patients with diabetic kidney disease
Naguib, M., & Rashed, L. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.06.022 · Cited by 46
Chen, P., Shi, X., Xu, X., Lin, Y., Shao, Z., Wu, R., & Huang, L. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.09.006 · Cited by 48
“Recent study has illustrated that the expression of FoxO1 protein in the kidney tissues from patients with DKD was significantly reduced compared with healthy controls [38].”
BackgroundDu, M., Wang, Q., Li, W. J., Ma, X., Wu, L., Guo, F., Zhao, S., Huang, F., Wang, H., & Qin, G. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.066 · Cited by 40
Wang, L., & Li, H. (2020) · Bioscience Reports · doi:10.1042/bsr20193653 · Cited by 38
“Moreover, the loss of TIMP3 exacerbates the progress of DN [17].”
Wang, Y., & He, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.630617 · Cited by 41
“This study suggests that the reduction of autophagy, especially in MCs, caused by TIMP3 deficiency may deteriorate DKD (Fiorentino et al., 2013).”
BackgroundMenghini, R., Uccioli, L., Vainieri, E., Pecchioli, C., Casagrande, V., Stoehr, R., Cardellini, M., Porzio, O., Rizza, S., & Federici, M. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0478-6 · Cited by 38
“TIMP3 and ADAM17 have been involved in the pathogenesis of diabetes and its complications in different models and tissues including peripheral atherosclerotic disease and diabetic microangiopathy nephropathy in humans and experimental models [8–14]; here, we assessed the role of TIMP3 and its targets in neuropathic an…”
BackgroundSelf-citationTubular β-catenin and FoxO3 interactions protect in chronic kidney disease
Khodo, S. N., Osaki, Y., Scarfe, L., Yang, H., Mignemi, M. P., Tonello, J. M., Saito‐Diaz, K., Neelisetty, S., Ivanova, A. V., Huffstater, T. M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135454 · Cited by 40
“given their target-specific actions unless a site-specific approach is feasible (66, 67).”
BackgroundRossi, C., Marzano, V., Consalvo, A., Zucchelli, M., Mortera, S. L., Casagrande, V., Mavilio, M., Sacchetta, P., Federici, M., Menghini, R., et al. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1074-y · Cited by 34
“Diabetes was induced by the injection of STZ as previously described [5].”
BackgroundMethodResultInfluentialSelf-citationSimulated microgravity inhibits C2C12 myogenesis via phospholipase D2-induced Akt/FOXO1 regulation
Baek, M., Ahn, C. B., Cho, H., Choi, J., Son, K. H., & Yoon, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-51410-7 · Cited by 35
Truong, L. D., Trostel, J., & García, G. (2015) · The FASEB Journal · doi:10.1096/fj.14-262493 · Cited by 35
“Moreover, in patients with diabetic nephropathy, a significant reduction in kidney TIMP3 was identified (55).”
BackgroundLay, A. C., Hale, L. J., Stowell-Connolly, H., Pope, R. J. P., Nair, V., Ju, W., Márquez, E., Rollason, R., Hurcombe, J., Hayes, B., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05427-1 · Cited by 32
Liu, P., Zhu, W., Wang, Y., Ma, G., Zhao, H., & Li, P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1142805 · Cited by 36
“The expression of metalloproteinase inhibitor 3 gene (Timp3) was down-regulated in the kidneys of diabetic patients, in the kidneys of STZ-induced diabetic mice, and in GMCs treated with high glucose (101).”
BackgroundThe Endothelium Abridges Insulin Resistance to Premature Aging
Avogaro, A., de Kreutzenberg, S. V., Federici, M., & Fadini, G. P. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000262 · Cited by 35
“More recently, we demonstrated that loss of TIMP3 can alter FoxO1 localization at endothelial and mesangial levels, potentially promoting dysfunctional activation of autophagy in the kidney.(53) Because autophagy is a powerful antiaging mechanism in the kidney, we hypothesized that hyperglycemia”
Self-citationLncRNA TUG1 ameliorates diabetic nephropathy by inhibiting miR-21 to promote TIMP3-expression.
Wang, F., Gao, X., Zhang, R., Zhao, P., Sun, Y., & Li, C. (2019) · Europe PMC (PubMed Central) · Cited by 34
Kim, E. Y., Roshanravan, H., & Dryer, S. E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.07.011 · Cited by 30
Protective role of green tea on diabetic nephropathy—A review
Mohib, M. M., Rabby, S. M. F., Paran, T. Z., Hasan, M. M., Ahmed, I., Hasan, N., Sagor, M. A. T., & Mohiuddin, M. S. (2016) · Cogent Biology · doi:10.1080/23312025.2016.1248166 · Cited by 31
“Besides, diabetic kidneys also suffer from low level of TIMP3 and FoxO1; conversely, STAT1 level was noticed high (Fiorentino et al., 2013).”
BackgroundAhmed, M., Lai, T. H., Hwang, J. S., Zada, S., Pham, T. M., & Kim, D. R. (2019) · Cells · doi:10.3390/cells8111321 · Cited by 31
Easy-to-use strategy for reference gene selection in quantitative real-time PCR experiments
Klenke, S., Renckhoff, K., Engler, A., Peters, J., & Frey, U. H. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1305-8 · Cited by 29
Pontrelli, P., Oranger, A., Barozzino, M., Divella, C., Conserva, F., Fiore, M. G., Rossi, R., Papale, M., Castellano, G., Simone, S., et al. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1656-3 · Cited by 26
“partments, supporting its possible involvement in the pathogenesis of diabetic complications [11, 15, 16].”
BackgroundSelf-citationTIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice
Stöhr, R., Kappel, B. A., Carnevale, D., Cavalera, M., Mavilio, M., Arisi, I., Fardella, V., Cifelli, G., Casagrande, V., Rizza, S., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.007 · Cited by 25
Self-citationA Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction
Mavilio, M., Marchetti, V., Fabrizi, M., Stöhr, R., Marino, A., Casagrande, V., Fiorentino, L., Cardellini, M., Kappel, B., Monteleone, I., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.027 · Cited by 23
“Allanimalprocedures are in accordance with the Guide for the Care and Use of Laboratory Animals published by the NIH (publication no. 85–23, revised 1996), approved by the University Hospital of Tor Vergata Animal Care Facility, and have been previously described (Fiorentino et al., 2013a).”
BackgroundMethodSelf-citationShang, J., Wang, S., Jiang, Y., Duan, Y., Cheng, G., Liu, D., Xiao, J., & Zhao, Z. (2019) · Scientific Reports · doi:10.1038/s41598-019-39298-9 · Cited by 23
TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy
Casagrande, V., Federici, M., & Menghini, R. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01766-y · Cited by 22
Self-citationSestrin2 Signaling Pathway Regulates Podocyte Biology and Protects against Diabetic Nephropathy
Ala, M. (2023) · Journal of Diabetes Research · doi:10.1155/2023/8776878 · Cited by 25
“Autophagy is a cellular mechanism that can remove dysfunctional organelles and misfolded proteins and maintain normal cellular homeostasis [64, 65].”
BackgroundRai, G. P., & Baird, S. K. (2020) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-10017-y · Cited by 25
Effects of FoxO1 on podocyte injury in diabetic rats
Guo, F., Zhang, Y., Wang, Q., Ren, L., Zhou, Y., Ma, X., Wu, L., & Qin, G. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.024 · Cited by 20
“Fiorentino also observed that loss of Foxo1 was associated with podocyte injury in models of DN by interacting with TIMP-3 [7].”
BackgroundZhu, D., Wu, X. Y., & Xue, Q. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00709-5 · Cited by 21
“TIMP3 is reported to exert important function in maintaining kidney homeostasis, and the down-regulation of TIMP3 is identified as a marker for DN [20].”
BackgroundPang, J., Xu, D., Zhang, X., Qu, J., Jiang, J., Suo, J., Li, T., Li, Y., & Peng, Z. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.02.020 · Cited by 20
Shi, X., Chang, M., Zhao, M., Shi, Y., & Zhang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113916 · Cited by 17
Wang, H., Zhang, Y. H., Xia, F., Zhang, W., Chen, P., & Guo-an, Y. (2019) · BMC Molecular and Cell Biology · doi:10.1186/s12860-019-0209-0 · Cited by 19
A proteomic atlas of kidney amyloidosis provides insights into disease pathogenesis
Charalampous, C. M., Dasari, S., McPhail, E. D., Theis, J. D., Vrana, J. A., Dispenzieri, A. A., Leung, N., Muchtar, E., Gertz, M. A., Ramírez-Alvarado, M., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.11.023 · Cited by 21
The critical role of dysregulated autophagy in the progression of diabetic kidney disease
Zhang, Z., Sun, Y., Xue, J., Jin, D., Li, X., Zhao, D., Lian, F., Qi, W., & Tong, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.977410 · Cited by 15
Casagrande, V., Iuliani, G., Menini, S., Pugliese, G., Federici, M., & Menghini, R. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.305 · Cited by 14
“At 5weeks after STZorNa-Citrate buffer administration, DBA/2J mice were randomly divided into the following four treatment groups: (1) vehicle buffer (PBS), (2) G3C12 free peptide, (3) G3C12-NTIMP3 peptide, and (4) G3C12T2GNTIMP3 peptide.”
BackgroundMethodSelf-citationLiu, T., Jin, Q., Yang, L., Mao, H., Ma, F., Wang, Y., Li, P., & Zhan, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1142276 · Cited by 21
Tissue Inhibitor of Metalloproteinase-3 Ameliorates Diabetes-Induced Retinal Inflammation
El‐Asrar, A. M. A., Ahmad, A., Nawaz, M. I., Siddiquei, M. M., Zutter, A. D., Vanbrabant, L., Gikandi, P. W., Opdenakker, G., & Struyf, S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.807747 · Cited by 15
Differentially methylated and expressed genes in familial type 1 diabetes
DASHTI, M. H., Nizam, R., Hebbar, P., Jacob, S. P., John, S. E., Channanath, A. M., Alkandari, H., Thanaraj, T. A., & Al‐Mulla, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-15304-5 · Cited by 16
PPBP as a marker of diabetic nephropathy podocyte injury via Bioinformatics Analysis
Zhang, F., Jiang, N., Gao, Y., Fan, Z., Li, Q., Ke, G., Li, B., Wu, Q., Xu, R., & Liu, S. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.08.087 · Cited by 15
Guo, F., Wang, Q., Zhou, Y., Wu, L., Ma, X., Liu, F., Huang, F., & Qin, G. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25249 · Cited by 13
“Current researches have identified that FoxO1 interacts with PI3K/Akt/mTORC1 pathway or TIMP3/STAT1 to ameliorate the pathogenesis of DN, which are supplements to our JOURNAL OF CELLULAR BIOCHEMISTRY FOXO1 INHIBIT ECM PROTEIN SECRETION 81 research [Fiorentino et al., 2013; Das et al., 2014].”
BackgroundSpanò, D. P., & Scilabra, S. D. (2022) · Membranes · doi:10.3390/membranes12020211 · Cited by 15
“First, Timp3-null mice challenged with streptozocin exhibited increased signs of fibrosis, thicker glomerular basement membrane and albuminuria compared to wild-type mice [96].”
BackgroundDarmayanti, S., Lesmana, R., Meiliana, A., & Abdulah, R. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210101105253 · Cited by 11
ADAMs family in kidney physiology and pathology
Zhu, H., Wang, J., Nie, W., Armando, I., & Han, F. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103628 · Cited by 12
Bao, X.-H., Xu, J., Chen, Y., Yang, C., & Ye, S. (2014) · Aging Clinical and Experimental Research · doi:10.1007/s40520-014-0207-1 · Cited by 9
“[31] also demonstrated a previously unknown mechanism response to a chronic hyperglycemic stress caused by diabetes, in which the absence of Timp3, a metalloprotease inhibitor, exacerbates renal damage.”
BackgroundGuo, Z., Niu, Q., Mi, X., Yang, B., Cai, M., & Liang, Y. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-08957-6 · Cited by 8
“The involvement of the TIMP3/ADAM17 pathway in the progression of DKD has already been shown [39, 41].”
Bohara, S., Bagheri, A., Ertugral, E. G., Radzikh, I., Sandlers, Y. I., Jiang, P., & Kothapalli, C. R. (2024) · Journal of Biological Engineering · doi:10.1186/s13036-024-00457-w · Cited by 10
“In humans with T2DM and hypertension, elevated levels of TIMPs-1 and 3, TIMP-1: MMP-2 ratio, and TIMP-1: MMP-9 ratio were reported [58, 59], which mirrors our observations in this study.”
ResultBarron, L., Khadka, S., Schenken, R. S., He, L., Blenis, J., Blagg, J., Chen, S.-F., Tsai, K., & Boyer, T. (2021) · F&S Science · doi:10.1016/j.xfss.2021.09.003 · Cited by 7
TIMP3/Wnt axis regulates gliosis of Müller glia
Hung, J., Tsai, P., Aala, W., Chen, C.-C., Chiou, S., Wong, T., Tsai, K., Hsu, S., & Wu, L. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167087 · Cited by 5
Targeting FoxO1 in traditional Chinese medicine for the treatment of diabetes
Yang, L., Fu, B. M., & Zeng, Y. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.12.8 · Cited by 5
“Moreover, high levels of glucose in kidney cells can trigger a cascade of reactions called the AKT pathway, which breaks down FoxO1 (7, 9).”
BackgroundInfluentialBayat, R., Salehi, Z., Dalili, S., & Mashayekhi, F. (2025) · Health Science Reports · doi:10.1002/hsr2.70480 · Cited by 4
Wang, Y., Du, Z., Li, X., Zhang, K., Qin, Q., Luo, C., Wu, J., Zhang, H., Liu, S., Xu, Z., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.105560 · Cited by 7
“Studies in other cell types suggest TIMP3 may drive autophagy via FoxO1/STAT1 59, 60 , but this mechanism in chondrocytes requires further exploration.”
Chen, H., Chen, L., Chen, Y., Guo, Q., & Lin, S. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1367399 · Cited by 2
“Another study has con fi rmed that TIMP-3 de fi ciency contributes to the development of diabetic nephropathy through FoxO1/ STAT1 interactions (Fiorentino et al., 2013).”
BackgroundMethodHypoxia-Induced Metabolic Reprogramming and Markings of Cell Fate in Concentric Arterial HypertrophyPreprint
de Almeida, L. F., Smith, J. P., Yamaguchi, M., Medrano, S., Martini, A. G., Matsuoka, D., Juśkiewicz, Z. J., Isakson, B. E., Yamaguchi, H., Trevisan-Silva, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.09.663881 · Cited by 3
Inhibition of retinal neovascularization by Dendrobium polysaccharides: a review
Liu, D., Chen, X., & Cai, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1584553 · Cited by 2
“The imbalance between MMPs and TIMPs affects the degradation and innovation of ECM components and is considered a potential biomarker for diabetes and its complexity (Cabral-Pacheco et al., 2020; Fiorentino et al., 2013).”
Targeting FoxO1 in cardiovascular diseases: Mechanisms and therapeutic potential
Wu, X., Du, X., & Lu, C. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108122 · Cited by 4
Beclin1-associated complex in autophagy and regulation
Behura, A., & Dhiman, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90142-0.00004-9 · Cited by 1
Insulin Treatment Attenuates Renal ADAM17 and ACE2 Shedding in Akita Diabetic Mice
Salem, E., Grobe, N., & Elased, K. M. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
BaoJiang, X.-H., & Chen, X. (2014)
The Role of Matrix Metalloproteinases in the Pathogenesis of Atrial Fibrillation
Li, D., & Zhang, J. (2022) · International Journal of Clinical and Experimental Medicine Research · doi:10.26855/ijcemr.2022.10.005
Liu, Y., Sun, B., Yang, J., Zeng, T., Shi, L., & Xu, N. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.153112
Li, M., Peng, H., Ding, S., Wei, Y., Zhang, L., Zhou, Z., Tang, H., Shi, P., Liang, Y., Li, G., et al. (2025) · Clinical ophthalmology · doi:10.2147/opth.s556592
Macrophage FOXO1 Inhibition Protects Against Hyperglycaemia‐Associated Kidney Injury
Zhu, H., Liu, Q., Yang, L., 张辰宇, Zhang, Y., Zhao, R., Zheng, Z.-Y., Wang, X., Li, L., Zhang, L., et al. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70296
Metadata
- Authors
- Fiorentino, L., Cavalera, M., Menini, S., Marchetti, V., Mavilio, M., Fabrizi, M., Conserva, F., Casagrande, V., Menghini, R., Pontrelli, P., Arisi, I., D'Onofrio, M., Lauro, D., Khokha, R., Accili, D., Pugliese, G., Gesualdo, L., Lauro, R., & Federici, M.
- Affiliations
- University of Rome Tor Vergata (IT)
- Sapienza University of Rome (IT)
- University of Bari Aldo Moro (IT)
- European Brain Research Institute (IT)
- University of Toronto (CA)
- Columbia University (US)
- Corresponding author
- Federici, Massimo
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2013-02-12
- Volume
- 5
- Issue
- 3
- Pages
- 441-455
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3598083
- OpenAlex
- W1917997699
- Cited by
- 98
- References
- 53
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 6 · 2019: 12 · 2018: 5 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 10 · 2013: 9
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/3.0/ (tdm)
- creativecommons.org/licenses/by/3.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK057539)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Keywords
- TIMP-3, diabetic nephropathy, FOXO1, STAT1, ADAM17, autophagy, albuminuria, mesangial expansion, therapeutic target
- MeSH terms
- Forkhead Box Protein O1, Albuminuria, Animals, Autophagy, Biopsy, Cell Line, Diabetes Mellitus, Experimental, Diabetic Nephropathies, Gene Expression Regulation, Humans, Kidney Glomerulus, Transfection, Signal Transduction, Mice, Knockout, Tissue Inhibitor of Metalloproteinase-3, Gene Expression Profiling, RNA Interference, Mesangial Cells, STAT1 Transcription Factor, Mice, Forkhead Transcription Factors, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.